This was my first experience of the biennial conference organised by the International Society on Priorities in Health Care. The society was founded in 1996 at the University of Birmingham in the UK and returned to its spiritual home 20… Read More »Meeting round-up: Priorities 2016
Every Monday our authors provide a round-up of some of the most recently published peer reviewed articles from the field. We don’t cover everything, or even what’s most important – just a few papers that have interested the author. Visit our Resources… Read More »Chris Sampson’s journal round-up for 1st August 2016
Every Monday our authors provide a round-up of some of the most recently published peer reviewed articles from the field. We don’t cover everything, or even what’s most important – just a few papers that have interested the author. Visit our Resources… Read More »Chris Sampson’s journal round-up for 11th July 2016
Every Monday our authors provide a round-up of some of the most recently published peer reviewed articles from the field. We don’t cover everything, or even what’s most important – just a few papers that have interested the author. Visit our Resources… Read More »Chris Sampson’s journal round-up for 27th June 2016
Every Monday our authors provide a round-up of some of the most recently published peer reviewed articles from the field. We don’t cover everything, or even what’s most important – just a few papers that have interested the author. Visit our Resources… Read More »Chris Sampson’s journal round-up for 30th May 2016
Today, two new studies are published examining different aspects of the observed increase in the risk of mortality associated with weekend admission, the so-called ‘weekend effect’. In the first [disclaimer: I am an author of this], the results of a… Read More »The ‘Weekend Effect’ (and what it means for research and policy)
The recently delivered Queen’s speech set out the government’s plan for “a 7-day NHS”. This vision is a reaction to alarming statistics that mortality rates are increased by 11% for patients admitted to hospital on a Saturday, and 16% if… Read More »The economics of a 7-day NHS
In a previous post I asked whether the study by Claxton et al can or should inform the cost-effectiveness threshold used by NICE. The authors argued that, “it is the expected health effects … of the average displacement within the… Read More »Identifying the effect of expenditure on health outcomes: another small comment on Claxton et al
The cost-effectiveness threshold utilised by health technology assessment agencies, such as NICE in the United Kingdom, below which new medical technologies and interventions are considered cost-effective, is frequently discussed. NICE currently use a threshold of £20,000 to £30,000 per quality… Read More »Do we really need to change the cost-effectiveness threshold?
NICE recently completed their appraisal of the hepatitis C drug sofosbuvir. However, as has been reported in the media, NHS England will not be complying with the guidance within the normal time period. The cost of a 24 week course of sofosbuvir is almost… Read More »Sofosbuvir: a fork in the road for NICE?